Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathee Till

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Journal of the National Cancer Institute|January 24, 2018
Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715)Dawn L Hershman, Joseph M Unger, Katherine D Crew, et al.
Cancer|September 16, 2024
Smoking prevalence and association with sociodemographic variables in cancer clinical trial participantsCary A Presant, Cathee Till, Riha Vaidya, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 26, 2014
Plasma tocopherols and risk of prostate cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Demetrius Albanes, Cathee Till, Eric A Klein, et al.
Cancer|May 11, 2016
Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention TrialDouglas K Price, Cindy H Chau, Cathee Till, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 15, 2010
Transition of a clinical trial into translational research: the prostate cancer prevention trial experiencePhyllis J Goodman, Catherine M Tangen, Alan R Kristal, et al.
Carcinogenesis|December 12, 2017
Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention TrialLi Tang, Mary E Platek, Song Yao, et al.
Carcinogenesis|July 21, 2011
Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention TrialLi Tang, Song Yao, Cathee Till, et al.
The Journal of Urology|October 19, 2010
Androgen receptor CAG repeat length and association with prostate cancer risk: results from the prostate cancer prevention trialDouglas K Price, Cindy H Chau, Cathee Till, et al.
Plos One|May 9, 2015
Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention TrialCindy H Chau, Douglas K Price, Cathee Till, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 11, 2012
Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasterideAlan R Kristal, Cathee Till, Catherine M Tangen, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Journal of the National Cancer Institute|January 24, 2018
Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715)Dawn L Hershman, Joseph M Unger, Katherine D Crew, et al.
Cancer|September 16, 2024
Smoking prevalence and association with sociodemographic variables in cancer clinical trial participantsCary A Presant, Cathee Till, Riha Vaidya, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 26, 2014
Plasma tocopherols and risk of prostate cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Demetrius Albanes, Cathee Till, Eric A Klein, et al.
Cancer|May 11, 2016
Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention TrialDouglas K Price, Cindy H Chau, Cathee Till, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 15, 2010
Transition of a clinical trial into translational research: the prostate cancer prevention trial experiencePhyllis J Goodman, Catherine M Tangen, Alan R Kristal, et al.
Carcinogenesis|December 12, 2017
Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention TrialLi Tang, Mary E Platek, Song Yao, et al.
Carcinogenesis|July 21, 2011
Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention TrialLi Tang, Song Yao, Cathee Till, et al.
The Journal of Urology|October 19, 2010
Androgen receptor CAG repeat length and association with prostate cancer risk: results from the prostate cancer prevention trialDouglas K Price, Cindy H Chau, Cathee Till, et al.
Plos One|May 9, 2015
Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention TrialCindy H Chau, Douglas K Price, Cathee Till, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 11, 2012
Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasterideAlan R Kristal, Cathee Till, Catherine M Tangen, et al.
Pageof 7